1981
DOI: 10.1097/00006534-198167020-00008
|View full text |Cite
|
Sign up to set email alerts
|

Results of Argon Laser Exposure of Capillary Hemangiomas of Infancy—Preliminary Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
11
0
1

Year Published

1984
1984
2001
2001

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(12 citation statements)
references
References 0 publications
0
11
0
1
Order By: Relevance
“…21 Laser treatment of hemangiomas has gained favor for treatment of shallow hemangiomas. 23 The flash pump laser emits a yellow light which is selectively absorbed by the heme moiety. This laser, in a pulsed mode, can deliver high energy in short bursts, which lessen conductive heat burn and super selectively ablate vascular tissue.…”
Section: Discussionmentioning
confidence: 99%
“…21 Laser treatment of hemangiomas has gained favor for treatment of shallow hemangiomas. 23 The flash pump laser emits a yellow light which is selectively absorbed by the heme moiety. This laser, in a pulsed mode, can deliver high energy in short bursts, which lessen conductive heat burn and super selectively ablate vascular tissue.…”
Section: Discussionmentioning
confidence: 99%
“…Der Argonlaser eignet sich zur Koagulation oberflächlicher vaskulärer Fehlund Neubildung wie kapilläre Häman-giome, Teleangiektasien unterschiedlicher Genese und Spider Nävi [12,86]. Bei zarten oberflächlichen Gefäßen ist aufgrund geringerer Nebenwirkungen dem gepulsten Farbstofflaser mittlerweile der Vorzug zu geben.…”
Section: Hämangiometeleangiektasien Spider Näviunclassified
“…As increasing numbers of patients are treated. certain treatment parameters have been established regarding different patient and lesion types [Cosman, 1980; Noe Apfelberg et al, 1976Apfelberg et al, , 1978Apfelberg et al, , 1979aApfelberg et al, ,b, 1981aArndt et al, 1983;Gilchrest et al, 1982;Maser et al, 1983;Solomon et al, 1968;Goldman et al, 19761. Scarring has been the main complication and has varied from 5 to 38% [Cosman, 1980;Noe et al, 1980;Apfelberg et al, 1976Apfelberg et al, , 1978Apfelberg et al, , 1981aGilchrest et al, 1982;Maser et al, 1983;Dixon et al, 19841. This report details a well-controlled series of patients with PWS treated in like manner by one surgeon with carefully controlled parameters and follow-up. The data presented augment the existing literature regarding the selection and treatment of patients with this deforming problem.…”
Section: Introductionmentioning
confidence: 99%